SE8602405D0 - Ny formulering - Google Patents

Ny formulering

Info

Publication number
SE8602405D0
SE8602405D0 SE8602405A SE8602405A SE8602405D0 SE 8602405 D0 SE8602405 D0 SE 8602405D0 SE 8602405 A SE8602405 A SE 8602405A SE 8602405 A SE8602405 A SE 8602405A SE 8602405 D0 SE8602405 D0 SE 8602405D0
Authority
SE
Sweden
Prior art keywords
new formulation
preparation
aqueous solution
pharmaceutical formulation
plasminogen activator
Prior art date
Application number
SE8602405A
Other languages
English (en)
Other versions
SE8602405L (sv
SE462016B (sv
Inventor
M D Johnston
H Berger
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858513358A external-priority patent/GB8513358D0/en
Priority claimed from GB858521705A external-priority patent/GB8521705D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SE8602405D0 publication Critical patent/SE8602405D0/sv
Publication of SE8602405L publication Critical patent/SE8602405L/sv
Publication of SE462016B publication Critical patent/SE462016B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE8602405A 1985-05-28 1986-05-27 Foerfarande foer iordningsstaellande av en lyofiliserad farmaceutisk sammansaettning med vaevnadsplasminogen-aktivator, t-pa SE462016B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858513358A GB8513358D0 (en) 1985-05-28 1985-05-28 Formulation
GB858521705A GB8521705D0 (en) 1985-08-31 1985-08-31 Formulation

Publications (3)

Publication Number Publication Date
SE8602405D0 true SE8602405D0 (sv) 1986-05-27
SE8602405L SE8602405L (sv) 1986-11-29
SE462016B SE462016B (sv) 1990-04-30

Family

ID=26289290

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8602405A SE462016B (sv) 1985-05-28 1986-05-27 Foerfarande foer iordningsstaellande av en lyofiliserad farmaceutisk sammansaettning med vaevnadsplasminogen-aktivator, t-pa

Country Status (22)

Country Link
US (2) US4929444A (sv)
JP (1) JPH0759517B2 (sv)
AU (1) AU567236B2 (sv)
BE (1) BE904830A (sv)
CA (1) CA1300008C (sv)
CH (1) CH665356A5 (sv)
DE (1) DE3617752A1 (sv)
DK (1) DK163173C (sv)
ES (2) ES8800601A1 (sv)
FI (1) FI85335C (sv)
FR (1) FR2583984B1 (sv)
GB (1) GB2176702B (sv)
GR (1) GR861366B (sv)
HU (1) HU195733B (sv)
IL (1) IL78938A (sv)
IT (1) IT1191926B (sv)
LU (1) LU86444A1 (sv)
NL (1) NL8601355A (sv)
NO (1) NO171345C (sv)
NZ (1) NZ216307A (sv)
PT (1) PT82646B (sv)
SE (1) SE462016B (sv)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1191925B (it) * 1985-05-28 1988-03-31 Wellcome Found Soluzione acquosa parenterale di attivatore di plasminogeno dei tessuti e procedimento di preparazione
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
US5034225A (en) * 1985-12-17 1991-07-23 Genentech Inc. Stabilized human tissue plasminogen activator compositions
US4777043A (en) * 1985-12-17 1988-10-11 Genentech, Inc. Stabilized human tissue plasminogen activator compositions
IE59895B1 (en) * 1986-05-12 1994-04-20 Wellcome Found Medicaments containing tissue plasminogen activator
US4976959A (en) * 1986-05-12 1990-12-11 Burroughs Wellcome Co. T-PA and SOD in limiting tissue damage
GB8619098D0 (en) * 1986-08-05 1986-09-17 Wellcome Found Combination
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
US5342616A (en) * 1988-06-20 1994-08-30 The Wellcome Foundation Limited Method of administering tissue plasminogen activator
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
DE3835350A1 (de) * 1988-10-17 1990-04-19 Boehringer Mannheim Gmbh Aktivierung von gentechnologisch hergestellten, in prokaryonten exprimierten antikoerpern
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
DE3942142A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh Stabilisierung von glykosyliertem t-pa
WO1992011866A1 (en) * 1991-01-14 1992-07-23 Duke University LAMININ SEQUENCE AS tPA ACTIVATOR
DE69312493T2 (de) * 1992-06-03 1998-01-15 Genentech Inc Varianten des gewebeplasminogenaktivators mit verbesserter therapeutischer wirkung
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
KR19990066981A (ko) * 1995-10-23 1999-08-16 윌리엄 뉴우 치료용 맥관형성억제 조성물 및 방법
NZ330537A (en) * 1995-12-13 2001-06-29 Childrens Medical Center Kringle 5 rerion of plasminogen as an endothelial cell proliferation inhibitor
DK0827751T3 (da) * 1996-09-06 2003-03-31 Chemo Sero Therapeut Res Inst Medicinsk præparat indeholdende vævsplasminogenaktivator og nicotinamid
CA2459120A1 (en) * 2001-09-07 2003-03-20 Kenneth S. S. Chang Human tissue urokinase type plasminogen activator formulation
US20040091465A1 (en) * 2002-06-26 2004-05-13 Zachary Yim Therapeutic antiangiogenic compositions and methods
US7670810B2 (en) * 2003-06-20 2010-03-02 Illumina, Inc. Methods and compositions for whole genome amplification and genotyping
US7491263B2 (en) * 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
PL1879599T3 (pl) * 2005-04-20 2014-03-31 Hutchinson Fred Cancer Res Sposoby, kompozycje i wyroby do zwiększania przeżywalności komórek, tkanek, narządów i organizmów

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998947A (en) * 1973-11-30 1976-12-21 Pierre Fabre S.A. Process for obtaining a plasminogen activator
FR2252842B1 (sv) * 1973-12-03 1977-11-04 Fabre Sa Pierre
DE3015699C2 (de) * 1979-04-26 1982-07-15 Asahi Kasei Kogyo K.K., Osaka Herstellung eines Plasminogen-Aktivators
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
JPS5951220A (ja) * 1982-08-02 1984-03-24 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
WO1984001714A1 (en) * 1982-10-29 1984-05-10 Mitsui Toatsu Chemicals Novel plasminogen activator, process for its preparation, and thrombolytic drug containing the same
AU554862B2 (en) * 1982-12-14 1986-09-04 Implico B.V. Plasminogen activator isolated by affinity chromatography
NZ206699A (en) * 1982-12-30 1989-08-29 Bio Response Inc Process for the production of serum independent cell lines
JPS59196824A (ja) * 1983-04-21 1984-11-08 Kowa Co 吸着防止剤
DE3584902D1 (de) * 1984-02-29 1992-01-30 Asahi Chemical Ind Waessrige loesung eines darin in erhoehter konzentration aufgeloesten gewebe-plasminogen-aktivators und herstellungsverfahren.
DE3439980A1 (de) * 1984-11-02 1986-05-07 Behringwerke Ag, 3550 Marburg Verfahren zur reinigung sowie pasteurisierung von urokinase
EP0201153A3 (en) * 1985-02-09 1987-10-07 Beecham Group Plc Modified enzyme and process for its preparation
GB8513358D0 (en) * 1985-05-28 1985-07-03 Wellcome Found Formulation
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
JPH0672105B2 (ja) * 1985-10-02 1994-09-14 持田製薬株式会社 血栓溶解剤及びその製法

Also Published As

Publication number Publication date
DE3617752A1 (de) 1986-12-04
AU5796486A (en) 1986-12-04
IL78938A0 (en) 1986-09-30
NO862096L (no) 1986-12-01
PT82646B (pt) 1989-01-30
DK163173C (da) 1992-06-22
FR2583984A1 (fr) 1987-01-02
FI862227A (fi) 1986-11-29
GB2176702B (en) 1989-07-05
NL8601355A (nl) 1986-12-16
CH665356A5 (de) 1988-05-13
IT8648065A0 (it) 1986-05-27
JPH0759517B2 (ja) 1995-06-28
FR2583984B1 (fr) 1989-06-02
BE904830A (fr) 1986-11-27
ES555353A0 (es) 1987-11-16
HUT41638A (en) 1987-05-28
FI85335C (sv) 1992-04-10
SE8602405L (sv) 1986-11-29
AU567236B2 (en) 1987-11-12
DE3617752C2 (sv) 1988-06-30
ES557374A0 (es) 1988-06-01
US4929444A (en) 1990-05-29
ES8800601A1 (es) 1987-11-16
DK246786A (da) 1986-11-29
HU195733B (en) 1988-07-28
GB2176702A (en) 1987-01-07
PT82646A (en) 1986-06-01
GR861366B (en) 1986-09-29
JPH06183995A (ja) 1994-07-05
IL78938A (en) 1993-02-21
GB8612780D0 (en) 1986-07-02
NO171345B (no) 1992-11-23
ES8802439A1 (es) 1988-06-01
SE462016B (sv) 1990-04-30
DK246786D0 (da) 1986-05-27
DK163173B (da) 1992-02-03
LU86444A1 (fr) 1986-12-05
IT1191926B (it) 1988-03-31
FI862227A0 (fi) 1986-05-27
US4968617A (en) 1990-11-06
NO171345C (no) 1993-03-03
FI85335B (fi) 1991-12-31
NZ216307A (en) 1989-10-27
CA1300008C (en) 1992-05-05

Similar Documents

Publication Publication Date Title
SE8602405L (sv) Ny formulering
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
ES2065906T3 (es) Produccion de proteinas en formas activas.
FI103111B1 (sv) Förfarande för framställning av sackarinderivat användbara som inhibitorer för proteolytiskt enzym
DE3650358D1 (de) Diphosphonate enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Arthrosis.
DE3683266D1 (de) Antibiotikum a 40926 mannosyl aglycon.
DE68904462D1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten.
DK103987D0 (da) Substituerede 1,3,4,9-tetrahydropyranooe3,4-baaindol-l-eddikesyrer, deres fremstilling og anvendelse som laegemidler
FR2577048B1 (fr) Reactif pour le dosage par hemagglutination des anticorps contre les toxines bacteriennes, procede de preparation et son application
DK325387D0 (da) 4-benzyloxy-3-pyrrolin-2-on-1-yl-acetamid samt dets fremstilling og anvendelse
PT85454A (de) Verwendung von 15-deoxyspergualin als arzneimittel
ES2060440T3 (es) Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos.
DE3064798D1 (en) Pentadecapeptide, process for the preparation thereof and immunopotentiating agent
KR870002847A (ko) 인간 피브리노겐 제제의 가열 처리방법
ES2056801T3 (es) Oxirano-seudooligosacaridos, procedimiento para su preparacion, su utilizacion y preparados farmaceuticos.
FI873632A (fi) Nya analoger av hypokalcemiska polypeptidfoereningar, som bevarar organismens kalcium, deras framstaellning, deras anvaendning som laekemedel och dessa innehaollande sammansaettningar.
GR3015373T3 (en) 2-Halogen-substituted N-indolyl sulfonic-acid amides, process for their preparation and their pharmaceutical use.
ES2015772A6 (es) Procedimiento e obtencion de nuevos derivados del 5-fluorouracilo, concretamente los n1-acil-sustituidos-n3-orto-toluil-5-fluorouracilo.
ES8708115A1 (es) Procedimiento para la fabricacion de un agente aromatizante para productos alimenticios
BG48625A1 (en) Method for preparing soluble apirogen mucopolysaccharide substance for receiving stable injection solutions

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8602405-6

Effective date: 19941210

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8602405-6

Format of ref document f/p: F